0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Thyroid Hormone and the Skeleton: A Bone of Contention

David S. Cooper, MD
JAMA. 1988;259(21):3175. doi:10.1001/jama.1988.03720210065033.
Text Size: A A A
Published online

In 1891, von Recklinghausen1 reported severe skeletal demineralization in a 23-year-old woman with thyrotoxicosis. Since then, numerous studies have detailed the abnormal bone and mineral dynamics in states of thyroid hormone excess. (See reference 2 for a review.) Briefly stated, thyroid hormones directly stimulate osteoclasts to enhance bone resorption. This leads to mild hypercalcemia, with concomitant suppression of serum parathyroid hormone levels, modest elevations in levels of bone alkaline phosphatase, and negative calcium balance. While clinically overt thyrotoxic bone disease is uncommon, numerous studies have demonstrated decreased bone mineral content in hyperthyroidism, using a variety of noninvasive techniques2; not surprisingly, postmenopausal women are the most severely affected. Several reports also document that the bone loss in hyperthyroidism may be partially reversible with treatment of the underlying thyroid disorder.3

See also p 3137.

Although the decline in skeletal mass associated with endogenous thyrotoxicosis is interesting from a pathophysiological

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Figures

Tables

References

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();